We've documented the recent delay in Cronos' financials, and Medipharm's potential links to bulk sales and purchases of biomass. Our last structure on Medipharm Labs highlighted some margin slippa read more

We've documented the recent delay in Cronos' financials, and Medipharm's potential links to bulk sales and pu read more

Well, another day, another lawsuit. This time it's around a purchaser flaking on some $9MM+ of payables owing to Medipharm Labs over a white-label agreement gone bad. I'm a naturally curious guy, read more

Well, another day, another lawsuit. This time it's around a purchaser flaking on some $9MM+ of payables owing read more

In looking at $LABS’ last two sets of financials, we’ve noted their optionality and compensation levels. For the most part, how much the *suits* are getting paid is a relatively subjective exerci read more

In looking at $LABS’ last two sets of financials, we’ve noted their optionality and compensation levels. read more